ALHC Company Profile and Key Details

ALHC has shown sold momentum, gaining 6.86% over the past week and 32.83% over the past quarter, though year-to-date performance is up 15.14%. Short-term trend indicators are mixed aligned (SMA20 -2.63%, SMA50 -2.85%, SMA200 19.58%). The stock’s 14-day RSI is 46.32 (neutral), while the ATR of 0.84 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -14.45% below its high and over 75.66% above its low. Average 10-day trading volume of 8.26 million shares is slightly above the 3-month average of 6.15 million, indicating heightened recent market interest.

Alignment Healthcare, Inc. has 206.73 million shares outstanding. The public float is 186.88 million shares, elevated short interest at 12.34% of float. This equals 24.81 million shares. The short ratio is 4.7 days. Institutional investors hold 109.71% of the float. Insiders own 2.74%. General Atlantic (SPV) GP, LLC holds 67.95 million shares, Warburg Pincus Partners II, L.P. has 19.97 million shares and Warburg Pincus Partners II Holdings, L.P. has 19.97 million shares. Over the past six months, insider transactions show net selling. They sold 1.69 million shares across 35 transactions.

Alignment Healthcare, Inc. generated EPS of -$0.12 over the past year. Five-year average earnings growth is -22.95%. The latest quarter delivered EPS of $0.17. The next quarter is forecast at -$0.15. Next year's EPS is expected at $16.46. Analyst sentiment is neutral. Analyst rating data shows there are 7 Strong Buy ratings, 2 Buy ratings, 7 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $30.00 to $16.00. The high target offers 121.89% upside. The low target suggests 18.34% downside. The mean target is $21.19. This offers 56.73% upside. Alignment Healthcare, Inc. earnings surprise history is a mixed track record. The quarter that ended July 30, 2026, missed forecasts by 30.77%. The prior quarter beat by 500.0%. Over the last six quarters, Apple has recorded several small beats. These include -58.33% in May 01, 2025.

Alignment Healthcare, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $14.33. This means the shares are trading below this model’s fair value.

Alignment Healthcare, Inc. (NASDAQ:ALHC) closed at $13.52 USD, losing -$1.04 (-7.14%) from the previous close of $14.56. The stock is currently within 5% of its 52-week low $13.05 and $25.12. With a market capitalization of about $2.80 billion, Alignment Healthcare, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.05). Key stats such as the average daily volume over the past year has been around 6.15 million shares, trading with heavier-than-usual volume. Headquartered in Orange, CA, Alignment Healthcare, Inc. operates in the Healthcare sector and the Medical - Healthcare Plans industry. Led by CEO John E. Kao, the company employs approximately 1,849 people and listed since March 26, 2021. Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer.

Alignment Healthcare, Inc. trades at a P/E ratio of 68.32, slightly above the S&P 500 average, with a price-to-sales ratio of 0.62 and a price-to-book ratio of 10.66 reflecting a rich premium to book value. The P/FCF stands at 13.76, also above market averages. Compared to sector medians, Alignment Healthcare, Inc. P/S is trading at a discount to the sector, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Alignment Healthcare, Inc. (NASDAQ:ALHC) shares are up 15.14% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Alignment Healthcare, Inc. trading at a premium to the broader market with a P/E of 68.32. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $16.20, suggesting 19.82% upside. Our AI forecast model points to short-term weakness (-12.5% over two weeks), a medium-term rise (132.25% over three months), and a longer-term gain (104.22% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Alignment Healthcare, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -12.5%, with price expected at $11.83 by August 18, 2026, within a range of $10.45 to $13.23 3-Month Outlook: Projected rise of 132.25%, reaching $31.40 by October 30, 2026, with a range of $31.12 to $31.72. 1-Year Outlook: Projected gain of 104.22%, with price at $27.61 by August 04, 2027, within a range of $28.94 to $30.31.